NO20032471L - Farnesyltransferaseinhibitorer - Google Patents
FarnesyltransferaseinhibitorerInfo
- Publication number
- NO20032471L NO20032471L NO20032471A NO20032471A NO20032471L NO 20032471 L NO20032471 L NO 20032471L NO 20032471 A NO20032471 A NO 20032471A NO 20032471 A NO20032471 A NO 20032471A NO 20032471 L NO20032471 L NO 20032471L
- Authority
- NO
- Norway
- Prior art keywords
- farnesyl transferase
- farnesyltransferase
- inhibiting
- thiazoles
- patient
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72723000A | 2000-11-30 | 2000-11-30 | |
| US09/912,677 US20020115640A1 (en) | 2000-11-30 | 2001-07-25 | Farnesyltransferase inhibitors |
| PCT/US2001/043168 WO2002074747A1 (en) | 2000-11-30 | 2001-11-30 | Farnesyltransferase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20032471D0 NO20032471D0 (no) | 2003-05-30 |
| NO20032471L true NO20032471L (no) | 2003-07-25 |
Family
ID=24921844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20032471A NO20032471L (no) | 2000-11-30 | 2003-05-30 | Farnesyltransferaseinhibitorer |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US20020115640A1 (cs) |
| EP (1) | EP1339695B1 (cs) |
| JP (1) | JP2004519503A (cs) |
| KR (1) | KR20030060968A (cs) |
| CN (1) | CN1487924A (cs) |
| AR (1) | AR035375A1 (cs) |
| AT (1) | ATE323681T1 (cs) |
| BG (1) | BG107908A (cs) |
| BR (1) | BR0112028A (cs) |
| CA (1) | CA2430619A1 (cs) |
| CY (1) | CY1106104T1 (cs) |
| CZ (1) | CZ20031804A3 (cs) |
| DE (1) | DE60118955T2 (cs) |
| DK (1) | DK1339695T3 (cs) |
| EC (1) | ECSP034634A (cs) |
| ES (1) | ES2261340T3 (cs) |
| HU (1) | HUP0600331A2 (cs) |
| IL (2) | IL156212A0 (cs) |
| MX (1) | MXPA03004879A (cs) |
| MY (1) | MY136181A (cs) |
| NO (1) | NO20032471L (cs) |
| NZ (1) | NZ526313A (cs) |
| PE (1) | PE20020687A1 (cs) |
| PL (1) | PL363637A1 (cs) |
| PT (1) | PT1339695E (cs) |
| SA (1) | SA01220565B1 (cs) |
| SI (1) | SI1339695T1 (cs) |
| SK (1) | SK286686B6 (cs) |
| UY (1) | UY27046A1 (cs) |
| WO (1) | WO2002074747A1 (cs) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2606226A1 (en) * | 2005-04-27 | 2006-11-02 | University Of Florida Research Foundation, Inc. | Materials and methods for enhanced degradation of mutant proteins associated with human disease |
| JP4592548B2 (ja) * | 2005-08-24 | 2010-12-01 | 株式会社エヌ・ティ・ティ・ドコモ | 送信電力制御方法及び移動通信システム |
| US7722316B2 (en) * | 2005-09-13 | 2010-05-25 | Rolls-Royce Power Engineering Plc | Acoustic viscous damper for centrifugal gas compressor |
| US7790770B2 (en) | 2005-11-23 | 2010-09-07 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| TW200806284A (en) * | 2006-03-31 | 2008-02-01 | Alcon Mfg Ltd | Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma |
| US8084477B2 (en) * | 2007-10-31 | 2011-12-27 | Bristol-Myers Squibb Company | Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production |
| US20110086834A1 (en) * | 2008-06-26 | 2011-04-14 | Amgen Inc. | Alkynyl alcohols as kinase inhibitors |
| SG10201403562UA (en) * | 2010-11-26 | 2014-08-28 | Reza Ghotbi | Implant for the treatment or prevention of an aneurysm |
| CN105693617B (zh) * | 2014-11-24 | 2018-06-08 | 中国科学院大连化学物理研究所 | 一种tmsn3参与的还原环化反应制备4-咪唑甲醛衍生物的方法 |
| WO2017062552A1 (en) | 2015-10-07 | 2017-04-13 | Tc1 Llc | Resonant power transfer systems having efficiency optimization based on receiver impedance |
| CN112851508B (zh) * | 2019-11-27 | 2025-02-25 | 广东东阳光药业股份有限公司 | 一种巴洛沙韦中间体的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000507590A (ja) * | 1996-04-03 | 2000-06-20 | メルク エンド カンパニー インコーポレーテッド | ファルネシル―タンパク質トランスフェラーゼ阻害剤 |
| US6297239B1 (en) * | 1997-10-08 | 2001-10-02 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
| DE69923849T2 (de) * | 1998-08-27 | 2006-01-12 | Pfizer Products Inc., Groton | Quinolin-2-on-derivate verwendbar als antikrebsmittel |
-
2001
- 2001-07-25 US US09/912,677 patent/US20020115640A1/en not_active Abandoned
- 2001-10-24 MY MYPI20014939A patent/MY136181A/en unknown
- 2001-11-29 AR ARP010105568A patent/AR035375A1/es unknown
- 2001-11-29 UY UY27046A patent/UY27046A1/es not_active Application Discontinuation
- 2001-11-29 PE PE2001001198A patent/PE20020687A1/es not_active Application Discontinuation
- 2001-11-30 BR BR0112028-0A patent/BR0112028A/pt not_active IP Right Cessation
- 2001-11-30 EP EP01273519A patent/EP1339695B1/en not_active Expired - Lifetime
- 2001-11-30 CN CNA018223427A patent/CN1487924A/zh active Pending
- 2001-11-30 PL PL01363637A patent/PL363637A1/xx not_active Application Discontinuation
- 2001-11-30 HU HU0600331A patent/HUP0600331A2/hu unknown
- 2001-11-30 IL IL15621201A patent/IL156212A0/xx active IP Right Grant
- 2001-11-30 SI SI200130573T patent/SI1339695T1/sl unknown
- 2001-11-30 SK SK823-2003A patent/SK286686B6/sk not_active IP Right Cessation
- 2001-11-30 DK DK01273519T patent/DK1339695T3/da active
- 2001-11-30 NZ NZ526313A patent/NZ526313A/en unknown
- 2001-11-30 ES ES01273519T patent/ES2261340T3/es not_active Expired - Lifetime
- 2001-11-30 DE DE60118955T patent/DE60118955T2/de not_active Expired - Fee Related
- 2001-11-30 JP JP2002573756A patent/JP2004519503A/ja active Pending
- 2001-11-30 MX MXPA03004879A patent/MXPA03004879A/es active IP Right Grant
- 2001-11-30 CZ CZ20031804A patent/CZ20031804A3/cs unknown
- 2001-11-30 CA CA002430619A patent/CA2430619A1/en not_active Abandoned
- 2001-11-30 WO PCT/US2001/043168 patent/WO2002074747A1/en active IP Right Grant
- 2001-11-30 KR KR10-2003-7007345A patent/KR20030060968A/ko not_active Ceased
- 2001-11-30 PT PT01273519T patent/PT1339695E/pt unknown
- 2001-11-30 AT AT01273519T patent/ATE323681T1/de not_active IP Right Cessation
- 2001-12-02 SA SA01220565A patent/SA01220565B1/ar unknown
-
2003
- 2003-05-29 IL IL156212A patent/IL156212A/en not_active IP Right Cessation
- 2003-05-30 NO NO20032471A patent/NO20032471L/no not_active Application Discontinuation
- 2003-05-30 EC EC2003004634A patent/ECSP034634A/es unknown
- 2003-06-13 BG BG107908A patent/BG107908A/bg unknown
-
2006
- 2006-06-23 CY CY20061100852T patent/CY1106104T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0112965A (pt) | Derivados de 3-indolil-4-fenil-1h-pirrol-2,5-diona como inibidores de glocogênio sintase cinase-3beta | |
| NO20032471L (no) | Farnesyltransferaseinhibitorer | |
| NO20051788L (no) | Hydantoinderivater og deres anvendelse som TACE-inhibitorer | |
| NO20051600L (no) | 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer | |
| DE602004019548D1 (de) | Kondensierte heterocyclen als inhibitoren von glutamatracemase (muri) | |
| NO971537L (no) | Peptidylforbindelser og deres terapeutiske anvendelse som inhibitorer for metalloproteaser | |
| BR0014075A (pt) | Inibidores de quinase como agentes terapêuticos | |
| BR0307960A (pt) | N-aminoacetil-pirrolidina-2-carbonitrilas e seu uso como inibidores de ddp-iv | |
| PL401636A1 (pl) | Związek benzoimidazolowy, jego zastosowanie oraz zawierająca go kompozycja farmaceutyczna | |
| NO20060972L (no) | Pyridylderivater og deres anvendelse som terapeutiske midler | |
| NO20051339L (no) | Anvendelse av lkB-kinaseinbibitorer ved behandling av smerte. | |
| ECSP003699A (es) | Inhibidores de fab i | |
| BR0308787A (pt) | Inibidores de metaloproteinase de n-substituìdos-heteroarilóxi-aril-espiro-pirimidina- 2,4,6-triona | |
| NO20060973L (no) | Pyridylderivater og deres anvendelse som tempeutiske midler | |
| ATE409189T1 (de) | Farnesyl transferase-hemmende 6- heterocyclylmethyl-chinolin und chinazol-derivate | |
| DE60042401D1 (de) | Fab-i inhibitoren | |
| WO2003106450A8 (de) | Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren | |
| ATE380797T1 (de) | Prenyl-transferase inhibitoren | |
| TW200504019A (en) | Diphenylpyridine derivatives, preparation thereof and application thereof in therapeutics | |
| NO20015857D0 (no) | Nye derivater og analoger av galantamin | |
| DE602004018811D1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren | |
| MXPA04008303A (es) | Inhibidores de la farnesil proteina transferasa como agentes antitumorales. | |
| BRPI0408893A (pt) | benzimidazóis cìclicos | |
| DK1644385T3 (da) | Siliciumforbindelser og deres anvendelse | |
| PT1292290E (pt) | Composicoes farmaceuticas que compreendem derivados de acriloil-distamicina e inibidores de topoisomerase 1 e ii |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ERR | Erratum |
Free format text: I PATENTTIDENDE NR. 36/05 BLE PATENTSOKNAD NR. 20032471 FEILAKTIG KUNNGJORT HENLAGT. SOKNADEN ER FORTSATT UNDER BEHANDLING Free format text: I PATENTTIDENDE NR. 36/05 BLE PATENTSOKNAD NR. 20032471 FEILAKTIG KUNNGJORT HENLAGT. SOKNADEN ER FORTSATT UNDER BEHANDLING. |
|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |